Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1 3Phase 2/3 2

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 4NET 3Gastrointestinal 3Thoracic 2Lymphoid 2Gynecologic 2Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Liver Neoplasms 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Positron Emission Tomography Computed Tomography × Gastrointestinal × Clear all
NCT03851237 2026-05-08

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Washington University School of Medicine

Phase 1 Completed
69 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05172310 2021-12-29

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Karolinska University Hospital

Phase 1 Recruiting
410 enrolled
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT01744054 2018-03-05

Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

Washington University School of Medicine

Phase 1 Terminated
57 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡